FDA Outlines Criteria for Skipping Trial Consent in Emergencies

Clinical Trials Advisor
A A
New FDA requirements regarding emergency research on incapacitated patients stress that sponsors must attempt to get permission from the patient’s family to continue a trial that was started without consent and allow patients to opt out once they are conscious.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00